Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures
NCT03678753
Epilepsy, Idiopathic Generalized, Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT Number: NCT00497835
An accelerometer with transmitting ability is worn on the wrist. Data of movements during seizures will be analyzed to upgrade algorithm that will identify seizures.
Looking for future studies?
Notify Me1 day–65 year
All sexes
Observational
Patients undergoing Video-EEG telemetry will wear movement sensor on their wrist. The sensor will transmit continuous data to a laptop. Seizures' data (tonic or clonic) will be analyzed and transformed into an algorithm (up-graded existing preliminary algorithm).
In the second phase the algorithm will need to identify seizure events within one minute of the onset.
Both specificity ("false positive") and sensitivity ("false negative) will be than calculated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Biolert
Industry
Epilepsy Alert Device - Epilert Performance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03678753
Epilepsy, Idiopathic Generalized, Nervous System Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT04557085
Focal Seizure, Nervous System Diseases
Shanghai, China
View Trial DetailsNCT05614063
Brain Diseases, Central Nervous System Diseases
Mobile, Alabama, United States
View Trial DetailsNCT02304029
Brain Diseases, Central Nervous System Diseases
Marseille, France
View Trial Details